| Programmed cell senescence during mammalian embryonic development D Muñoz-Espín, M Cañamero, A Maraver, G Gómez-López, J Contreras, ... Cell 155 (5), 1104-1118, 2013 | 1359 | 2013 |
| Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo CE Tadokoro, G Shakhar, S Shen, Y Ding, AC Lino, A Maraver, JJ Lafaille, ... The Journal of experimental medicine 203 (3), 505-511, 2006 | 721 | 2006 |
| Telomerase reverse transcriptase delays aging in cancer-resistant mice A Tomás-Loba, I Flores, PJ Fernández-Marcos, ML Cayuela, A Maraver, ... Cell 135 (4), 609-622, 2008 | 577 | 2008 |
| Delayed ageing through damage protection by the Arf/p53 pathway A Matheu, A Maraver, P Klatt, I Flores, I Garcia-Cao, C Borras, JM Flores, ... Nature 448 (7151), 375-379, 2007 | 543 | 2007 |
| VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis E Lombardo, A Maraver, I Espinosa, A Fernández-Arias, JF Rodriguez Virology 277 (2), 345-357, 2000 | 217 | 2000 |
| The Arf/p53 pathway in cancer and aging A Matheu, A Maraver, M Serrano Cancer research 68 (15), 6031-6034, 2008 | 162 | 2008 |
| VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus … E Lombardo, A Maraver, JR Castón, J Rivera, A Fernández-Arias, ... Journal of virology 73 (8), 6973-6983, 1999 | 157 | 1999 |
| C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly JR Castón, JL Martı́nez-Torrecuadrada, A Maraver, E Lombardo, ... Journal of virology 75 (22), 10815-10828, 2001 | 151 | 2001 |
| Anti‐aging activity of the Ink4/Arf locus A Matheu, A Maraver, M Collado, I Garcia‐Cao, M Cañamero, C Borras, ... Aging Cell 8 (2), 152-161, 2009 | 130 | 2009 |
| Therapeutic effect of γ-secretase inhibition in Kras G12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK A Maraver, PJ Fernandez-Marcos, D Herranz, M Cañamero, ... Cancer cell 22 (2), 222-234, 2012 | 122 | 2012 |
| EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours O Bornachea, M Santos, AB Martínez-Cruz, R García-Escudero, ... Scientific reports 2 (1), 1-12, 2012 | 107 | 2012 |
| NOTCH pathway inactivation promotes bladder cancer progression A Maraver, PJ Fernandez-Marcos, TP Cash, M Mendez-Pertuz, M Dueñas, ... The Journal of clinical investigation 125 (2), 824-830, 2015 | 106 | 2015 |
| The oligomerization domain of VP3, the scaffolding protein of infectious bursal disease virus, plays a critical role in capsid assembly A Maraver, A Oña, F Abaitua, D González, R Clemente, JA Ruiz-Díaz, ... Journal of virology 77 (11), 6438-6449, 2003 | 104 | 2003 |
| SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency D Herranz, A Maraver, M Canamero, G Gomez-Lopez, L Inglada-Perez, ... Oncogene 32 (34), 4052-4056, 2013 | 88 | 2013 |
| The C-terminal domain of the pVP2 precursor is essential for the interaction between VP2 and VP3, the capsid polypeptides of infectious bursal disease virus A Oña, D Luque, F Abaitua, A Maraver, JR Castón, JF Rodrı́guez Virology 322 (1), 135-142, 2004 | 73 | 2004 |
| Identification and molecular characterization of the RNA polymerase-binding motif of infectious bursal disease virus inner capsid protein VP3 A Maraver, R Clemente, JF Rodríguez, E Lombardo Journal of virology 77 (4), 2459-2468, 2003 | 69 | 2003 |
| An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors M Mancini, H Gal, N Gaborit, L Mazzeo, D Romaniello, TM Salame, ... EMBO molecular medicine 10 (2), 294-308, 2018 | 47 | 2018 |
| Notch inhibition overcomes resistance to Tyrosine Kinase Inhibitors in EGFR-driven lung adenocarcinoma EB Mur, S Bernardo, L Papon, M Mancini, E Fabbrizio, M Goussard, ... The Journal of clinical investigation, 2019 | 39 | 2019 |
| Troponin-I enhances and is required for oncogenic overgrowth S Casas-Tintó, A Maraver, M Serrano, A Ferrús Oncotarget 7 (33), 52631, 2016 | 28 | 2016 |
| Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma MJ Nokin, E Darbo, C Travert, B Drogat, A Lacouture, S San José, ... JCI insight 5 (15), 2020 | 20 | 2020 |
